Dexamphetamine—a restricted stimulant drug used to treat narcolepsy and Attention Deficient Hyperactivity Disorder ...

Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

The company currently markets Auvelity (AXS-05) for treating major depressive disorder (MDD) and Sunosi (solriamfetol) for treating narcolepsy. Auvelity was launched in the United States in 2022 for ...

Access to the live webcasts of these events, as well as archived recordings, will be available under the "Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals ...

Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda said it's laser-focused on six pipeline assets that could each reel in ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline make it a strong buy for 2025.

People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

Very early indications from the study show that drugs used to treat chronic pain and the sleep disorder narcolepsy could potentially be repurposed to treat depression. Since 2017 the international ...

In each of these situations, knowledge about the disorder and its treatments may be helpful. For more pervasive anxiety, seeing a therapist or psychologist may be helpful. Since narcolepsy is rare ...